申请人:Guillemont Jerôme Emile Georges
公开号:US20140163038A1
公开(公告)日:2014-06-12
The present invention is related to novel compounds of formula (I) that inhibit the activity of the Fab1 enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.
本发明涉及一种公式(I)的新化合物,其抑制Fab1酶的活性,因此在治疗细菌感染方面非常有用。此外,本发明还涉及包含这些化合物的药物组合物以及制备这些化合物的化学过程。